The Neurology Service was consulted and the patient was started on Dilantin for seizure prophylaxis.
The morning following the initial seizure activity, the patient again experienced two witnessed seizures, despite therapeutic Dilantin levels.
The patient continued on Dilantin with no further evidence of seizure activity.
A follow-up MRV of the head showed no evidence of venous spinous thrombosis and the patient was maintained off of anticoagulation.
The patient was maintained on IV fluids with nothing by mouth for several days.
However, on [**2149-9-25**], the patient underwent a subsequent speech and swallow evaluation with improved results.
A follow-up video swallowing study demonstrated adequate airway protection and the patient's diet was advanced to thin liquids and pureed the night prior to discharge.
A chest x-ray was notable for a question of lower lobe infiltrates and the patient was started on empiric antibiotics (ceftriaxone and Flagyl).
The patient continues with intermittent low-grade fevers without further signs of infection on empiric antibiotics.
On hospital day number 12, the patient's peripheral blood immunophenotyping results returned with the preliminary diagnosis of chronic lymphocytic leukemia with monoclonal B cells and mature T cell lineages.
Protonix 40 mg p.o.
Synthroid 25 micrograms p.o.
Clindamycin 600 mg IV t.i.d.
Ceftriaxone 1 gram IV q.
Colace 10 mg per rectum p.r.n.
Nystatin topical powder q.i.d.
DISCHARGE INSTRUCTIONS:  The patient is to be discharged to an acute rehabilitation facility for continued physical therapy as well as occupational therapy.
